Boston-based healthtech startup Biofourmis enters the Unicorn Club ($1 billion in valuation). The startup raised $300 million in its Series D funding round led ... Apr 27
CDC estimates that 6 in 10 American adults have 1 chronic disease whereas 4 in 10 suffer from 2 or more chronic diseases. Learn how ... Feb 26
Digital biomarker startup Koneksa has raised $45 million in their Series C funding round.... Feb 08
... Oct 20
Latest pharma news update... Oct 04
Japan covid news update... Aug 28
Dr. Vikram Raut Senior Consultant and Lead Liver Transplant Surgeon explains the signs and symptoms of liver disease and guides how to take care of ... May 01
Takeover to advance T-Cell Activator Solid Tumor Treatments and expand new Cancer Immunotherapy Portfolio... Mar 13
This collaboration will help Crescendo’s proprietary transgenic platform and engineering expertise are being used to build Humabody-based therapeutics against certain targets selected by ... Dec 11
Takeda Pharmaceutical Company Limited today announced top-line results from the Phase 3 clinical trial evaluating the efficacy and safety of the investigational drug TAK-... Dec 04
Takeda Pharmaceutical Company Limited completes its previously-announced sale of a portfolio of select products to Celltrion Inc... Dec 01
The digital networking space offers real-time, face-to-face engagement, which maximises chance encounters with other attendees... Nov 12
LogicBio Therapeutics Receives FDA Fast Track Designation for LB-001 for the Treatment of Methylmalonic Acidemia (MMA) ... Nov 04
Takeda expands COVID-19 vaccine supply in Japan through partnership with Moderna and Government of Japan ... Oct 29
Collaboration will leverage cloud and data-driven insights to accelerate drug development, increase operational agility, reduce technology costs and develop the workforce of the future ... Oct 13
Takeda establishes new cell drug manufacturing facility for research and development to support expansion of next-generation clinical programs ... Sep 19
CARE aims to create effective therapies with a positive safety profile for the COVID-19 pandemic and develop new drugs and antibodies specially designed to ... Aug 19
Glenmark Pharmaceuticals announced the appointment of Mr Dipankar Bhattacharjee as Independent Non-Executive Director on the Board of the organization... Aug 18
Novavax partners with Takeda for manufacturing and marketing covid vaccine in Japan... Aug 08
U.S. FDA Approves Takeda’s ALUNBRIG (brigatinib) as a first-line treatment option for patients diagnosed with rare and serious form of lung cancer ... May 23
Takeda Accelerates Transformation: Solid FY2019 Results, Confidence in FY2020 Growth Momentum ... May 14
... May 08
Portfolio includes select OTC and prescription products and two manufacturing facilities ... Apr 27
Multiple myeloma is a life-threatening rare blood cancer that arises from the plasma cells, a type of white blood cell that is made in ... Mar 12
Roche has donated $2 million worth of Actemra to China before the anti-inflammatory med was officially added to Chinese authorities COVID-19 treatment guidelines. ... Mar 06
-Advertisements-
.jpeg)
Friday, November 22, 2024
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)